跳至主要内容
临床试验/NCT00423241
NCT00423241终止不适用

A Prospective, Randomized, Exploratory Comparison of the SEMPERFLO* Pain Management System to a Commercially Available Pain Relief System in Subjects Undergoing Open Inguinal Hernia Repair

Ethicon, Inc.6 个研究点 分布在 1 个国家目标入组 7 人开始时间: 2007年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
发起方
Ethicon, Inc.
入组人数
7
试验地点
6
主要终点
Dynamic pain (pain measured with coughing) measured using a ten-point visual analog scale

研究概览

简要总结

This study will compare the clinical performance of the SEMPERFLO* Pain Management System with another commercial pain relief system using 0.5% bupivacaine following unilateral, open, inguinal hernia repair procedures.

*Trademark

详细描述

Pain will be evaluated up to 5 days after surgery Subjects will be followed for 30 days after surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Subject is a candidate for primary, non-emergent unilateral, open inguinal hernia repair procedure
  • •Subject is 18 years or older
  • •Subject must be willing to participate in the study, and provide informed consent to participate.

排除标准

  • •Subjects undergoing recurrent hernia repair;
  • •Subjects who plan to undergo another elective surgical procedure prior to the completion of this study;
  • •Subjects with known allergy to bupivacaine;
  • •Subjects with immunodeficiency diseases (including known HIV);
  • •Subjects with any findings identified by the surgeon that may preclude conduct of the study;
  • •Subjects who are known current alcohol and/or drug abusers;

研究组 & 干预措施

SEMPERFLO Pain Management System

Experimental

干预措施: SEMPERFLO Pain Management System (Device)

ON-Q PainBuster Post-Op Pain Relief System

Active Comparator

干预措施: ON-Q PainBuster Post-Op Pain Relief System (Device)

结局指标

主要结局

Dynamic pain (pain measured with coughing) measured using a ten-point visual analog scale

时间窗: twenty-four hours post procedure

次要结局

  • Numeric pain scale scores at rest and with coughing(24, 48, 72, 96, and 120 hours post-procedure)
  • Narcotic and non-narcotic analgesic usage(24, 48, 72, 96 and 120 hours post- procedure)

研究者

发起方
Ethicon, Inc.
申办方类型
Industry

研究点 (6)

Loading locations...

相似试验